Back to Search
DAVID EARL EDGERTON JR. D.O.
D.O.
Orthopaedic Surgery Physician
NPI: 1285879544IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
106240(MN)
Education
KANSAS CITY UNIVERSITY OF PHYSICIANS AND SURGEONS
Class of 2007
Research & Publications (20)
Current strategies for the inhibition of hepatic glucose production in type 2 diabetes.
PMID 19273123·Front Biosci (Landmark Ed)·2009
6-review
Inhaled insulin is associated with prolonged enhancement of glucose disposal in muscle and liver in the canine.
PMID 19098161·J Pharmacol Exp Ther·2009
7-preclinical
Inhibition of dipeptidyl peptidase-4 by vildagliptin during glucagon-like Peptide 1 infusion increases liver glucose uptake in the conscious dog.
PMID 18840785·Diabetes·2009
7-preclinical
Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
PMID 18029444·Am J Physiol Endocrinol Metab·2008
7-preclinical
Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.
PMID 18056788·Am J Physiol Endocrinol Metab·2008
7-preclinical
Triglyceride uptake and lipoprotein lipase-generated fatty acid spillover in the splanchnic bed of dogs.
PMID 17416801·Diabetes·2007
7-preclinical
Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
PMID 17684104·Am J Physiol Endocrinol Metab·2007
7-preclinical
A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
PMID 17308040·J Pharmacol Exp Ther·2007
7-preclinical
The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
PMID 16608886·Am J Physiol Endocrinol Metab·2006
7-preclinical
Insulin's direct effects on the liver dominate the control of hepatic glucose production.
PMID 16453026·J Clin Invest·2006
7-preclinical
Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose production.
PMID 16919547·Metabolism·2006
7-preclinical
Inhalation of human insulin is associated with improved insulin action compared with subcutaneous injection and endogenous secretion in dogs.
PMID 16963622·J Pharmacol Exp Ther·2006
4-observational
Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11beta hydroxysteroid dehydrogenase type 1 activity.
PMID 17065337·Diabetes·2006
7-preclinical
Inhalation of human insulin (exubera) augments the efficiency of muscle glucose uptake in vivo.
PMID 17130510·Diabetes·2006
8-other
Islet auto-transplantation into an omental or splenic site results in a normal beta cell but abnormal alpha cell response to mild non-insulin-induced hypoglycemia.
PMID 16162184·Am J Transplant·2005
7-preclinical
Inhalation of insulin (Exubera) is associated with augmented disposal of portally infused glucose in dogs.
PMID 15793257·Diabetes·2005
4-observational
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.
PMID 15784656·J Pharmacol Exp Ther·2005
7-preclinical
Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog.
PMID 14644767·Am J Physiol Endocrinol Metab·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1108 1ST ST SE
LITTLE FALLS, MN 56345 - Phone
- (320) 631-2200
Quick Facts
- NPI
- 1285879544
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile